Dissolution Assay of Bupropion/Naltrexone Hydrochloride Salts of Bilayer Composition Tablets Following the Development and Validation of a Novel HPLC Method
Compounded medicinal products containing bupropion hydrochloride (BUP·HCl) and naltrexone hydrochloride (NTX·HCl) are available as adjunct therapy for the management of weight in obese/overweight adults. The present work describes the development and validation of a novel RP-HPLC method for a simult...
Main Authors: | Anna Apostolidi, Chrystalla Protopapa, Angeliki Siamidi, Marilena Vlachou, Yannis Dotsikas |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Materials |
Subjects: | |
Online Access: | https://www.mdpi.com/1996-1944/15/23/8451 |
Similar Items
-
Probing the Release of Bupropion and Naltrexone Hydrochloride Salts from Biopolymeric Matrices of Diverse Chemical Structures
by: Angeliki Siamidi, et al.
Published: (2021-04-01) -
Mediterranean Diet and Naltrexone/Bupropion Treatment for Weight Loss in Overweight and Obese Breast Cancer Survivors and Non-Cancer Participants: A Pilot Randomized Controlled Trial
by: Cho AR, et al.
Published: (2020-09-01) -
The Review of pharmacological treatment registered for obesity in Poland
by: Julia Wyrwał, et al.
Published: (2024-02-01) -
Determination of Bupropion and Its Impurities via a Chaotropic Chromatography Method Following Analytical Quality-by-Design Principles for Method Development
by: Kostas Gkountanas, et al.
Published: (2022-09-01) -
Seizures After Overdoses of Bupropion Intake
by: Hasan Kara, et al.
Published: (2013-06-01)